Back
BioXcel Therapeutics Stock Price Chart
The dark truth about AI
Click here to learn more...
Sell
31
BTAI
BioXcel Therapeutics
Last Price:
0.41
Seasonality Move:
80.92%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAI is experiencing slight selling pressure.
BioXcel Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.42 | Sell |
| 20-day SMA: | 0.47 | Sell |
| 50-day SMA: | 0.55 | Sell |
| 200-day SMA: | 1.38 | Sell |
| 8-day EMA: | 0.43 | Sell |
| 20-day EMA: | 0.47 | Sell |
| 50-day EMA: | 0.55 | Sell |
| 200-day EMA: | 1.78 | Sell |
BioXcel Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 38.8 | Sell |
| Chaikin Money Flow: | 24525 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.4 - 0.6) | Sell |
| Bollinger Bands (100): | (0.46 - 0.82) | Sell |
BioXcel Therapeutics Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for BioXcel Therapeutics Stock
Is BioXcel Therapeutics Stock a Buy?
- BioXcel Therapeutics share price is 0.41 while BTAI 8-day simple moving average is 0.42, which is a Sell signal.
- The stock price of BTAI is 0.41 while BioXcel Therapeutics 20-day SMA is 0.47, which makes it a Sell.
- BioXcel Therapeutics 50-day simple moving average is 0.55 while BTAI share price is 0.41, making it a Sell technically.
- BTAI stock price is 0.41 and BioXcel Therapeutics 200-day simple moving average is 1.38, creating a Sell signal.
BTAI Technical Analysis vs Fundamental Analysis
Sell
31
BioXcel Therapeutics (BTAI)
is a Sell
Is BioXcel Therapeutics a Buy or a Sell?
-
BioXcel Therapeutics stock is rated a Sell
The current BioXcel Therapeutics [BTAI] share price is $0.41. The Score for BTAI is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
BioXcel Therapeutics Stock Info
Market Cap:
19.92M
Price in USD:
0.41
Share Volume:
248.2K
BioXcel Therapeutics 52-Week Range
52-Week High:
4.17
52-Week Low:
0.36
Sell
31
BioXcel Therapeutics (BTAI)
is a Sell
BioXcel Therapeutics Share Price Forecast
-
What is the BioXcel Therapeutics stock price today?
The BioXcel Therapeutics stock price is 0.41 USD today. -
Will BTAI stock go up or go down?
BioXcel Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is BioXcel Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioXcel Therapeutics is overvalued.
Is BioXcel Therapeutics Stock a Buy?
- BioXcel Therapeutics share price is 0.41 while BTAI 8-day exponential moving average is 0.43, which is a Sell signal.
- The stock price of BTAI is 0.41 while BioXcel Therapeutics 20-day EMA is 0.47, which makes it a Sell.
- BioXcel Therapeutics 50-day exponential moving average is 0.55 while BTAI share price is 0.41, making it a Sell technically.
- BTAI stock price is 0.41 and BioXcel Therapeutics 200-day simple moving average is 1.78, creating a Sell signal.
Fundamental Analysis of BioXcel Therapeutics
Is BioXcel Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.29 per share, and an increase next year of $0.21 per share.
Technical Analysis of BioXcel Therapeutics
Should I short BioXcel Therapeutics stock?
- BTAI Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting BioXcel Therapeutics is a Sell
- BioXcel Therapeutics Relative Strength Index (RSI) is 38.8, which suggest BioXcel Therapeutics is oversold
- The Bollinger Bands (25) for BioXcel Therapeutics is (0.4 - 0.6), which suggest BioXcel Therapeutics is a Sell
- The Bollinger Bands (100) for BioXcel Therapeutics is (0.46 - 0.82), which suggest BioXcel Therapeutics is a Sell
* BioXcel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.